Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
StAR-related lipid transfer protein 3 (STARD3), also known as metastatic lymph node 64 (MLN64), is a late endosomal integral membrane protein that plays a critical role in non-vesicular cholesterol transport. It creates membrane contact sites between the endoplasmic reticulum and late endosomes, facilitating the movement of cholesterol between these compartments. STARD3 is frequently overexpressed or co-amplified with HER2/ERBB2 in various malignancies, including breast, gastric, colorectal, and prostate cancers, where it promotes cell proliferation, migration, and invasion by altering membrane cholesterol distribution and tight junction organization. Consequently, STARD3 has emerged as an attractive therapeutic target in oncology. Pharmacological inhibitors, such as the first-in-class compound VS1, as well as repurposed drugs like digoxin and bexarotene (Targretin), target its cholesterol-binding START domain to disrupt cholesterol trafficking and attenuate cancer progression. However, targeting STARD3 presents safety concerns, including potential disruption of epithelial barrier function and cellular lipid homeostasis.
Inhibition of the START domain to block non-vesicular cholesterol transport
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on StAR-related lipid transfer protein 3 (STARD3) (STARD3).